 | • レポートコード：GIR-2104Z06448 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、緑内障治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。緑内障治療薬の種類別市場規模（経口タイプ、注射タイプ）、用途別市場規模（病院、クリニック、在宅医療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・緑内障治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Aerie Pharmaceuticals、Akorn Inc.、Alcon、Allergan plc、Bausch & Lomb Incorporated、Inotek Pharmaceuticals、Merck & Co. Inc、Pfizer Inc、Santen Pharmaceutical Co. Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口タイプ、注射タイプ ・用途別分析2016年-2026年：病院、クリニック、在宅医療 ・緑内障治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・緑内障治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・緑内障治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・緑内障治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・緑内障治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Glaucoma Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Glaucoma Treatment Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Glaucoma Treatment Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Glaucoma Treatment Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Type
Injection Type
Market segment by Application can be divided into
Hospital
Clinic
Home Care
The key market players for global Glaucoma Treatment Drugs market are listed below:
Aerie Pharmaceuticals
Akorn Inc.
Alcon
Allergan plc
Bausch & Lomb Incorporated
Inotek Pharmaceuticals
Merck & Co. Inc
Pfizer Inc
Santen Pharmaceutical Co. Ltd
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Glaucoma Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glaucoma Treatment Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market Analysis by Application
1.3.1 Overview: Global Glaucoma Treatment Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Glaucoma Treatment Drugs Market Size & Forecast
1.4.1 Global Glaucoma Treatment Drugs Sales in Value (2016-2026))
1.4.2 Global Glaucoma Treatment Drugs Sales in Volume (2016-2026)
1.4.3 Global Glaucoma Treatment Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Glaucoma Treatment Drugs Production Capacity Analysis
1.5.1 Global Glaucoma Treatment Drugs Total Production Capacity (2016-2026)
1.5.2 Global Glaucoma Treatment Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glaucoma Treatment Drugs Market Drivers
1.6.2 Glaucoma Treatment Drugs Market Restraints
1.6.3 Glaucoma Treatment Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Aerie Pharmaceuticals
2.1.1 Aerie Pharmaceuticals Details
2.1.2 Aerie Pharmaceuticals Major Business
2.1.3 Aerie Pharmaceuticals Glaucoma Treatment Drugs Product and Services
2.1.4 Aerie Pharmaceuticals Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Akorn Inc.
2.2.1 Akorn Inc. Details
2.2.2 Akorn Inc. Major Business
2.2.3 Akorn Inc. Glaucoma Treatment Drugs Product and Services
2.2.4 Akorn Inc. Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Alcon
2.3.1 Alcon Details
2.3.2 Alcon Major Business
2.3.3 Alcon Glaucoma Treatment Drugs Product and Services
2.3.4 Alcon Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Allergan plc
2.4.1 Allergan plc Details
2.4.2 Allergan plc Major Business
2.4.3 Allergan plc Glaucoma Treatment Drugs Product and Services
2.4.4 Allergan plc Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Bausch & Lomb Incorporated
2.5.1 Bausch & Lomb Incorporated Details
2.5.2 Bausch & Lomb Incorporated Major Business
2.5.3 Bausch & Lomb Incorporated Glaucoma Treatment Drugs Product and Services
2.5.4 Bausch & Lomb Incorporated Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Inotek Pharmaceuticals
2.6.1 Inotek Pharmaceuticals Details
2.6.2 Inotek Pharmaceuticals Major Business
2.6.3 Inotek Pharmaceuticals Glaucoma Treatment Drugs Product and Services
2.6.4 Inotek Pharmaceuticals Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Merck & Co. Inc
2.7.1 Merck & Co. Inc Details
2.7.2 Merck & Co. Inc Major Business
2.7.3 Merck & Co. Inc Glaucoma Treatment Drugs Product and Services
2.7.4 Merck & Co. Inc Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Pfizer Inc
2.8.1 Pfizer Inc Details
2.8.2 Pfizer Inc Major Business
2.8.3 Pfizer Inc Glaucoma Treatment Drugs Product and Services
2.8.4 Pfizer Inc Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Santen Pharmaceutical Co. Ltd
2.9.1 Santen Pharmaceutical Co. Ltd Details
2.9.2 Santen Pharmaceutical Co. Ltd Major Business
2.9.3 Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Product and Services
2.9.4 Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Glaucoma Treatment Drugs Sales by Manufacturer
3.1 Global Glaucoma Treatment Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glaucoma Treatment Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glaucoma Treatment Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Glaucoma Treatment Drugs Manufacturer Market Share
3.4.2 Top 6 Glaucoma Treatment Drugs Manufacturer Market Share
3.5 Global Glaucoma Treatment Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glaucoma Treatment Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glaucoma Treatment Drugs Market Size by Region
4.1.1 Global Glaucoma Treatment Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Glaucoma Treatment Drugs Revenue by Region (2016-2026)
4.2 North America Glaucoma Treatment Drugs Revenue (2016-2026)
4.3 Europe Glaucoma Treatment Drugs Revenue (2016-2026)
4.4 Asia-Pacific Glaucoma Treatment Drugs Revenue (2016-2026)
4.5 South America Glaucoma Treatment Drugs Revenue (2016-2026)
4.6 Middle East and Africa Glaucoma Treatment Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glaucoma Treatment Drugs Sales in Volume by Type (2016-2026)
5.2 Global Glaucoma Treatment Drugs Revenue by Type (2016-2026)
5.3 Global Glaucoma Treatment Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glaucoma Treatment Drugs Sales in Volume by Application (2016-2026)
6.2 Global Glaucoma Treatment Drugs Revenue by Application (2016-2026)
6.3 Global Glaucoma Treatment Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glaucoma Treatment Drugs Sales by Type (2016-2026)
7.2 North America Glaucoma Treatment Drugs Sales by Application (2016-2026)
7.3 North America Glaucoma Treatment Drugs Market Size by Country
7.3.1 North America Glaucoma Treatment Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Glaucoma Treatment Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glaucoma Treatment Drugs Sales by Type (2016-2026)
8.2 Europe Glaucoma Treatment Drugs Sales by Application (2016-2026)
8.3 Europe Glaucoma Treatment Drugs Market Size by Country
8.3.1 Europe Glaucoma Treatment Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Glaucoma Treatment Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glaucoma Treatment Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Glaucoma Treatment Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Glaucoma Treatment Drugs Market Size by Region
9.3.1 Asia-Pacific Glaucoma Treatment Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glaucoma Treatment Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glaucoma Treatment Drugs Sales by Type (2016-2026)
10.2 South America Glaucoma Treatment Drugs Sales by Application (2016-2026)
10.3 South America Glaucoma Treatment Drugs Market Size by Country
10.3.1 South America Glaucoma Treatment Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Glaucoma Treatment Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glaucoma Treatment Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Glaucoma Treatment Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Glaucoma Treatment Drugs Market Size by Country
11.3.1 Middle East & Africa Glaucoma Treatment Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glaucoma Treatment Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glaucoma Treatment Drugs Typical Distributors
12.3 Glaucoma Treatment Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Glaucoma Treatment Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Glaucoma Treatment Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Aerie Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Aerie Pharmaceuticals Major Business
Table 5. Aerie Pharmaceuticals Glaucoma Treatment Drugs Product and Services
Table 6. Aerie Pharmaceuticals Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Akorn Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Akorn Inc. Major Business
Table 9. Akorn Inc. Glaucoma Treatment Drugs Product and Services
Table 10. Akorn Inc. Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Alcon Basic Information, Manufacturing Base and Competitors
Table 12. Alcon Major Business
Table 13. Alcon Glaucoma Treatment Drugs Product and Services
Table 14. Alcon Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Allergan plc Basic Information, Manufacturing Base and Competitors
Table 16. Allergan plc Major Business
Table 17. Allergan plc Glaucoma Treatment Drugs Product and Services
Table 18. Allergan plc Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Bausch & Lomb Incorporated Basic Information, Manufacturing Base and Competitors
Table 20. Bausch & Lomb Incorporated Major Business
Table 21. Bausch & Lomb Incorporated Glaucoma Treatment Drugs Product and Services
Table 22. Bausch & Lomb Incorporated Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Inotek Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Inotek Pharmaceuticals Major Business
Table 25. Inotek Pharmaceuticals Glaucoma Treatment Drugs Product and Services
Table 26. Inotek Pharmaceuticals Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Merck & Co. Inc Basic Information, Manufacturing Base and Competitors
Table 28. Merck & Co. Inc Major Business
Table 29. Merck & Co. Inc Glaucoma Treatment Drugs Product and Services
Table 30. Merck & Co. Inc Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Inc Major Business
Table 33. Pfizer Inc Glaucoma Treatment Drugs Product and Services
Table 34. Pfizer Inc Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Santen Pharmaceutical Co. Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Santen Pharmaceutical Co. Ltd Major Business
Table 37. Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Product and Services
Table 38. Santen Pharmaceutical Co. Ltd Glaucoma Treatment Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Glaucoma Treatment Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Glaucoma Treatment Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Glaucoma Treatment Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Glaucoma Treatment Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Glaucoma Treatment Drugs Production Site of Key Manufacturer
Table 44. Global Glaucoma Treatment Drugs Sales by Region (2016-2021e) & (K Units)
Table 45. Global Glaucoma Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 46. Global Glaucoma Treatment Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Glaucoma Treatment Drugs Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Glaucoma Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 49. Global Glaucoma Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 50. Global Glaucoma Treatment Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Glaucoma Treatment Drugs Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Glaucoma Treatment Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 53. Global Glaucoma Treatment Drugs Price by Type (2021-2026) & (USD/Unit)
Table 54. Global Glaucoma Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 55. Global Glaucoma Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 56. Global Glaucoma Treatment Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Glaucoma Treatment Drugs Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Glaucoma Treatment Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 59. Global Glaucoma Treatment Drugs Price by Application (2021-2026) & (USD/Unit)
Table 60. North America Glaucoma Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 61. North America Glaucoma Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 62. North America Glaucoma Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Glaucoma Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Glaucoma Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 65. North America Glaucoma Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 66. North America Glaucoma Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 67. North America Glaucoma Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 68. Europe Glaucoma Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Glaucoma Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 70. Europe Glaucoma Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Glaucoma Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Glaucoma Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Glaucoma Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 74. Europe Glaucoma Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Glaucoma Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Glaucoma Treatment Drugs Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Glaucoma Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Glaucoma Treatment Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Glaucoma Treatment Drugs Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Glaucoma Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Glaucoma Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Glaucoma Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Glaucoma Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 84. South America Glaucoma Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 85. South America Glaucoma Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 86. South America Glaucoma Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Glaucoma Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Glaucoma Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. South America Glaucoma Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 90. South America Glaucoma Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. South America Glaucoma Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Glaucoma Treatment Drugs Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Glaucoma Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Glaucoma Treatment Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Glaucoma Treatment Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Glaucoma Treatment Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Glaucoma Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Glaucoma Treatment Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Glaucoma Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Glaucoma Treatment Drugs Typical Distributors
Table 103. Glaucoma Treatment Drugs Typical Customers
List of Figures
Figure 1. Glaucoma Treatment Drugs Picture
Figure 2. Global Glaucoma Treatment Drugs Sales Market Share by Type in 2020
Figure 3. Oral Type
Figure 4. Injection Type
Figure 5. Global Glaucoma Treatment Drugs Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Home Care
Figure 9. Global Glaucoma Treatment Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Glaucoma Treatment Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Glaucoma Treatment Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Glaucoma Treatment Drugs Sales (2016-2026) & (K Units)
Figure 31. Global Glaucoma Treatment Drugs Production Capacity (2016-2026) & (K Units)
Figure 32. Global Glaucoma Treatment Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Glaucoma Treatment Drugs Market Drivers
Figure 34. Glaucoma Treatment Drugs Market Restraints
Figure 35. Glaucoma Treatment Drugs Market Trends
Figure 36. Global Glaucoma Treatment Drugs Sales Market Share by Manufacturer in 2020
Figure 37. Global Glaucoma Treatment Drugs Revenue Market Share by Manufacturer in 2020
Figure 38. Glaucoma Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Glaucoma Treatment Drugs Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Glaucoma Treatment Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Glaucoma Treatment Drugs Sales Market Share by Region (2016-2026)
Figure 42. Global Glaucoma Treatment Drugs Revenue Market Share by Region (2016-2026)
Figure 43. North America Glaucoma Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 44. Europe Glaucoma Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Glaucoma Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 46. South America Glaucoma Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Glaucoma Treatment Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Global Glaucoma Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 49. Global Glaucoma Treatment Drugs Revenue Market Share by Type (2016-2026)
Figure 50. Global Glaucoma Treatment Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Glaucoma Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 52. Global Glaucoma Treatment Drugs Revenue Market Share by Application (2016-2026)
Figure 53. Global Glaucoma Treatment Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Glaucoma Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 55. North America Glaucoma Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 56. North America Glaucoma Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Glaucoma Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 58. Europe Glaucoma Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 59. Europe Glaucoma Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 60. Europe Glaucoma Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 61. Europe Glaucoma Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Glaucoma Treatment Drugs Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Glaucoma Treatment Drugs Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Glaucoma Treatment Drugs Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Glaucoma Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 66. South America Glaucoma Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 67. South America Glaucoma Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 68. South America Glaucoma Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 69. South America Glaucoma Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Glaucoma Treatment Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Glaucoma Treatment Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Glaucoma Treatment Drugs Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Glaucoma Treatment Drugs Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の緑内障治療市場規模・現状・予測（2021年-2027年） Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics glob…- 世界の抗緑内障薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-glaucoma Drug Market The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の抗緑内障薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-glaucoma Drug Market The global Anti-glaucoma Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
- 世界の眼瞼炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blepharitis Treatment Drugs Market The global Blepharitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…